Among the clinical and histological parameters, age (>55 years), WHO tumor grade (GBM), Karnofsky performance score (KPS) (below 90 %), and absence of IDH1 or IDH1 mutation status were significant negative predictors of OS. This evidence concerns the gene IDH1 and glioblastoma.